Launched in 2006 by Bio2Business Ltd, the Biotech Outsourcing Strategies Events bring together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships and forge new buyer/supplier business relationships. The established BOS Formula is built on 4 key pillars; Exhibition showcasing international CROs and CMOs; High Quality Content (delivered through the multi-stream programme); 1-to-1 Partnering; Informal Networking (BOS Events are known for being friendly, intimate events, which create the perfect conditions for networking!).
Since 2016 we are pleased to call Basel our home of our summer event (we run a sister event in Manchester, UK, in November 2020). Located in the heart of Europe, Basel is a unique Life Science Ecosystem which we are proud to support. BOS Basel 2020 will cover Discovery Outsourcing, Small Molecule CMC Outsourcing and Biologics CMC Outsourcing.
Designing Medicines of the Future and Integrating External Discovery Capabilities with Internal Projects
Dr Harri Salo, Head of Project Coordination, Orion Pharma
ABSTRACT: Dr. Harri Salo will speak about the integration of external discovery capabilities with the activities of internal projects. How to make most of external technological capabilities to support the early discovery programs? What are the experiences from a mid-sized pharma company point of view when working with various external partners and CRO’s during various discovery phases? Click here to Read More
Laxai Life Sciences Ltd Exhibiting at BOS Basel 2020
Bio2Business is pleased to extend a warm welcome to Laxai Life Sciences who are exhibiting at Booth Number 33. LAXAI’s GMP manufacturing sites (2) located in Hyderabad have a combined reactor capacity of 300KL and further expansions are currently taking place. The sites have in total 14 production blocks used for manufacturing of starting materials and intermediates and 8 clean rooms used for manufacturing of the API. The sites currently supply starting materials, advanced intermediates, and APIs to pharmaceutical, biotech, and animal health companies in US, EU, China, Japan, and ROW.
Bio2Business is delighted to welcome 2bind GmbH, Silver Sponsors at BOS Basel 2020.
2bind GmbH provides taylor-made biophysics services for drug discovery (Fragments/Compounds, Protein/RNA-targeted, HT Screening, Hit Validation, Hit Characterization), antibody development (Ab Stability Studies, Ab-Ag Interaction Studies, Pre-Formulation), aptamer characterization ((HT Screening, Kinetic and Thermodynamic Profiling) and protein biophysics (Interaction Analysis, Stability Analysis, Buffer Optimization, Enzyme-Stabilization) with a state-of-the-art method portfolio comprising nanoDSF, MST, BLI and ITC.
Dr Firelli Alonso, Senior Director, External Supply, BioTherapeutics & Vaccines Outsourcing, Pfizer, to present at BOS Basel 2020
Dr Firelli Alonso, Senior Director, External Supply, BioTherapeutics & Vaccines Outsourcing, Pfizer, will present in the Biologics CMC Outsourcing work-stream at BOS Basel 2020. Her confirmed presentation title is "Agile sourcing strategies for new therapeutic modalities".